12.55

2.62% 0.33

After Hours: 12.80 0.25 +1.99%

Benitec Biopharma Inc (BNTC)

Overview News Price History Financials Discussions Forecast Stock Split

Benitec Biopharma Inc stock is traded at $12.55, with a volume of 87,140. It is up +2.62% in the last 24 hours and down -4.27% over the past month. Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Previous Close:

$12.22

Open:

$12.21

24h Volume:

87,140

Relative Volume:

0.39

Market Cap:

$424.97M

Revenue:

$59,000

Net Income/Loss:

$-21.81M

P/E Ratio:

-1.1459

EPS:

-10.9518

Net Cash Flow:

$-18.07M

1W Performance:

+7.82%

1M Performance:

-4.27%

6M Performance:

+12.16%

1Y Performance:

+16.33%

1-Day Range:

$11.91

$12.57

1-Week Range:

$11.55

$13.11

52-Week Range:

$9.70

$17.15

Benitec Biopharma Inc Stock (BNTC) Company Profile

Name

Benitec Biopharma Inc

Sector

Healthcare (1114)

Industry

Biotechnology (624)

Phone

(510) 780-0819

Address

3940 TRUST WAY, HAYWARD, CA

Employee

Twitter

@BenitecLtd

Next Earnings Date

2024-11-11

Latest SEC Filings

BNTC's Discussions on Twitter

Compare BNTC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BNTC Benitec Biopharma Inc	12.55	413.80M	59,000	-21.81M	-18.07M	-10.95
VRTX Vertex Pharmaceuticals Inc	474.17	120.98B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	771.25	80.15B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	864.42	51.56B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	354.75	47.74B	3.21B	43.57M	221.36M	0.2405
ONC Beone Medicines Ltd Adr	336.16	37.38B	4.98B	69.59M	525.67M	0.5197

Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-07-25	Initiated	TD Cowen	Buy
Dec-16-24	Initiated	H.C. Wainwright	Buy
Dec-13-24	Initiated	Robert W. Baird	Outperform
Oct-16-24	Initiated	Oppenheimer	Outperform
Sep-12-24	Initiated	Guggenheim	Buy
Jul-22-24	Initiated	Leerink Partners	Outperform
Jun-13-24	Initiated	Piper Sandler	Overweight
Oct-05-20	Downgrade	Ladenburg Thalmann	Buy → Neutral
Apr-20-20	Initiated	Ladenburg Thalmann	Buy
Feb-26-16	Downgrade	Maxim Group	Buy → Hold
Dec-31-15	Reiterated	Maxim Group	Buy
Sep-16-15	Reiterated	Maxim Group	Buy

View All

Benitec Biopharma Inc Stock (BNTC) Latest News

Jan 26, 2026

Understanding Momentum Shifts in (BNTC) - Stock Traders Daily

Jan 26, 2026

Analyst Downgrade: Should I average down on GBTG stockJuly 2025 Earnings & Safe Capital Allocation Plans - baoquankhu1.vn

Jan 26, 2026

Jan 24, 2026

Hedge Fund Bets: Is Benitec Biopharma Inc forming a double bottomJuly 2025 Catalysts & Short-Term High Return Ideas - baoquankhu1.vn

Jan 24, 2026

Jan 18, 2026

Benitec Biopharma Limited (NASDAQ:BNTC) Sees Large Increase in Short Interest - MarketBeat

Jan 18, 2026

Jan 15, 2026

Avoiding Lag: Real-Time Signals in (BNTC) Movement - Stock Traders Daily

Jan 15, 2026

Jan 13, 2026

Aug Setups: Will Benitec Biopharma Inc face regulatory challengesTrade Entry Report & Accurate Intraday Trading Signals - baoquankhu1.vn

Jan 13, 2026

Aug Gainers: How supply chain issues affect Benitec Biopharma Inc stockEarnings Summary Report & Free High Accuracy Swing Entry Alerts - Bộ Nội Vụ

Jan 13, 2026

Citizens reiterates Market Outperform rating on Benitec BioPharma stock By Investing.com - Investing.com Canada

Jan 13, 2026

Jan 12, 2026

Market Wrap: What is the PEG ratio of Benitec Biopharma Inc2025 Growth vs Value & AI Powered Market Entry Ideas - baoquankhu1.vn

Jan 12, 2026

Baird reiterates Outperform rating on Benitec BioPharma stock at $30 target - Investing.com Canada

Jan 12, 2026

Baird reiterates Outperform rating on Benitec BioPharma stock at $30 target By Investing.com - Investing.com South Africa

Jan 12, 2026

Jan 11, 2026

Benitec Biopharma (BNTC) Reports Promising Results from BB-301 S - GuruFocus

Jan 11, 2026

Benitec Biopharma Inc. Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response - marketscreener.com

Jan 11, 2026

Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response - Sahm

Jan 11, 2026

Jan 10, 2026

Can Benitec Biopharma Inc. stock double in next 5 years2025 Fundamental Recap & AI Forecasted Entry and Exit Points - ulpravda.ru

Jan 10, 2026

Jan 09, 2026

Benitec Biopharma Limited (NASDAQ:BNTC) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Jan 09, 2026

Benitec Biopharma Limited (NASDAQ:BNTC) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Jan 09, 2026

Jan 08, 2026

Is Benitec Biopharma Inc. stock a buy before product launches2025 Momentum Check & AI Forecasted Entry/Exit Points - Улправда

Jan 08, 2026

Why Benitec Biopharma Inc. stock could be next big winnerStraddle and Strangle Trades & Superior Capital Trading Plans - bollywoodhelpline.com

Jan 08, 2026

Published on: 2026-01-09 06:38:29 - Улправда

Jan 08, 2026

Is Benitec Biopharma Inc. stock a buy on dipsGap Up & Verified Swing Trading Watchlist - Улправда

Jan 08, 2026